Back to Prevention

Why Is Opt-Out Testing Used in Hospitals?

Why Is Opt-Out Testing Used in Hospitals?
Bareback Guide 28 April 2026

Opt-out testing means that everyone having blood taken for another reason is tested for blood-borne viruses unless they decline. In England this has been introduced in emergency departments in areas of higher HIV prevalence, and it has found substantial numbers of people who did not know they were infected.

Why is it done this way round?

Because targeted testing depends on someone identifying themselves as at risk, and the people who remain undiagnosed are precisely those who do not. Asking everyone removes the need for anyone to raise the subject, to appear to be at risk, or to answer questions about their sex life in a busy department. It also removes the awkwardness for staff, who otherwise have to decide who to offer it to.

What is tested for?

Usually HIV, hepatitis B and hepatitis C together, since all three are blood-borne, all three are treatable or curable, and all three are frequently silent for years. Hepatitis C in particular is now curable with a course of tablets, and finding it is straightforwardly worthwhile.

Does it work?

Yes, and the yield has been higher than many expected. The programmes have identified people with advanced undiagnosed HIV who had attended healthcare repeatedly without being offered a test, along with large numbers of hepatitis cases. A meaningful proportion of those found had already been diagnosed previously and had disengaged from care, which is a different problem the same testing surfaces.

Can you decline?

Yes. Opt-out means you are told it is happening and can say no, not that consent is bypassed. In practice, information is usually given by leaflet or poster and by staff taking the sample, and declining is straightforward. Very few people do.

How are results handled?

Negative results are usually not communicated individually. A positive result triggers a follow-up contact and referral into specialist care, generally within days. Departments running these programmes have arrangements with HIV and hepatology services precisely so that a diagnosis in an emergency department does not become a result nobody acts on.

Is it confidential?

Results form part of your hospital record rather than a separate sexual health record, which is a genuine difference from testing at a sexual health clinic. If that matters to you, a sexual health service or a free postal kit offers the stricter separation. It is worth knowing rather than discovering afterwards.

Does it normalise testing?

That is part of the intention. A test offered to everyone carries no implication about the individual, which addresses one of the persistent obstacles: that being offered an HIV test can feel like being judged. Antenatal testing has worked on the same principle for decades and is one reason vertical transmission in the UK is now rare.

Does it replace sexual health testing?

No. An emergency department test covers blood-borne viruses only, so it says nothing about gonorrhoea, chlamydia or syphilis, and it does not include the rectal and throat swabs that find most bacterial infections. Treat it as a useful backstop rather than as your screen.

What should you do if offered?

Take it, even if you test regularly elsewhere, since it costs you nothing and the sample is already being taken. If you have declined in the past, it is worth reconsidering. And if you are told a result needs discussing, answer the call, because these programmes only achieve anything if the people they find are reached.

Where is it running?

England introduced it in emergency departments in areas of very high HIV prevalence and has expanded it since, with arrangements differing across the UK nations. If you attend a department in a participating area and have blood taken, you are likely to be tested unless you decline.

Is it cost effective?

Evaluations have found it so, largely because a late HIV diagnosis is expensive to manage and because hepatitis C cure prevents years of liver disease. Finding an infection early costs far less than treating the consequences of finding it late, which is the argument that has sustained the programmes.